Evidence map›Paper›PMID 41372171›Full record

ArticleNature communications2025

Ubiquitination by HRD1 is essential for TLR3 trafficking and its innate immune signaling.

Lianfeng Zhao, Zinan He, Yao Sun, Mengqi Sun, Zheyi Liu, Zhangsen Zhou, Ling Qi, Yuan Luo, Yewei Ji, Tingbo Liang

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lianfeng ZhaoZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zinan HeZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yao SunZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Mengqi SunZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zheyi LiuZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zhangsen ZhouShanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0001-7333-4624
Ling QiDepartment of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0001-8229-0184
Yuan LuoZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. luoyuan715@126.com.ORCID http://orcid.org/0009-0008-5633-409X
Yewei JiZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. ywji@cqmu.edu.cn.ORCID http://orcid.org/0000-0003-4960-9928
Tingbo LiangZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. liangtingbo@zju.edu.cn.ORCID http://orcid.org/0000-0003-0143-3353

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82171731, 82371737National Natural Science Foundation of China (National Science Foundation of China) 82188102National Natural Science Foundation of China (National Science Foundation of China) 82303596
6 · The paper itself

Abstract

Toll-like receptor 3 (TLR3), an innate immune sensor for double-stranded RNA (dsRNA), traffics from the endoplasmic reticulum (ER) after synthesis to endolysosomes for proteolytic cleavage and activation. However, the molecular mechanisms governing TLR3 trafficking remain largely unclear. Here, we identify the ER-resident E3 ligase HMG-CoA reductase degradation protein 1 (HRD1), a core component of ER-associated degradation (ERAD), as a key regulator that promotes TLR3 trafficking and downstream signaling. HRD1 deficiency in macrophages significantly impairs poly(I:C)-induced TLR3 signaling and inflammatory responses in vitro and in vivo, caused by a marked reduction in TLR3 transport into endolysosomes and subsequent proteolytic processing. Mechanistically, HRD1 mediates ubiquitination of ER-localized TLR3 at lysine 813, which is required for its recognition and sorting by the endosomal sorting complex required for transport (ESCRT) machinery. This HRD1 function is decoupled from its canonical ERAD activity and the ER stress sensor inositol-requiring enzyme 1 alpha (IRE1α). Hence, our study identifies a previously unrecognized mechanism controlling TLR3 signaling and links HRD1-mediated ubiquitination to immune sensor trafficking during innate immune responses.

Indexed as

Immunity, InnateToll-Like Receptor 3Ubiquitin-Protein LigasesAnimalsEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationEndosomesHEK293 CellsHumansMacrophagesMiceMice, Inbred C57BLMice, KnockoutPoly I-CProtein TransportSignal TransductionPoly I-CSYVN1 protein, humanSyvn1 protein, mouseTLR3 protein, humanTLR3 protein, mouseToll-Like Receptor 3Ubiquitin-Protein Ligases

Identifiers

PMID41372171
PMCPMC12804839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.